Cong Claire Xu, EVP, Clinical Development at NovaBridge Biosciences, sold NBP on Aug 31, 2026

Data as of Oct 27

▼ SELL$2.6K3,282 shares at $0.79Cong Claire Xu EVP, Clinical DevelopmentNBP NovaBridge Biosciences

Watch NBP

Traded: Aug 31, 2026
Disclosed: Sep 1, 2026
Filed: 1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

NBPSimilar stocks (S&P 500 (SPY)), rebased to NBP's price on the disclosure day

NBP since disclosure

−27.5%

after the sale

Similar stocks (SPY) since disclosure

+1.0%

S&P 500 (SPY)

Change in closing price from Sep 1, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on NBP →